How large is the lab automation in genomics market, and what is its growth trajectory?
The lab automation in genomics market size has grown rapidly in recent years. It will grow from $2.33 billion in 2024 to $2.7 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to the increased demand for precision medicine, rise in the complexity of genomic data, increased focus on genomic research, increased adoption in clinical diagnostics, demand for scalability and flexibility.
The lab automation in genomics market size is expected to see rapid growth in the next few years. It will grow to $4.82 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to the expansion of point-of-care testing, shift towards cloud-based solutions, focus on real-time and continuous monitoring, expansion of precision agriculture, rise of multi-omics integration. Major trends in the forecast period include the adoption of automated instruments, adoption of lab automation systems, automated technologies, cloud-based platforms.
Get Your Free Sample of The Global Lab Automation In Genomics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15206&type=smp
What key drivers have fueled the lab automation in genomics market’s development over the years?
The growing adoption of precision medicine is expected to propel the growth of lab automation in the genomics market going forward. Precision medicine is a personalized approach to healthcare that considers individual diversity in genes, environment, and lifestyle to deliver individualized medical therapies. The demand for precision medicine is rising due to several factors such as advances in genomics, targeted therapies, patient-centered care, and drug development. Precision medicine needs lots of genetic tests to find disease-related genes, pushing labs to process many samples fast and accurately, leading them to use automated systems. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the growing adoption of precision medicine is driving the growth of lab automation in the genomics market.
What is the segmentation for the lab automation in genomics market?
The lab automation in genomics market covered in this report is segmented –
1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Process: Continuous Automation System, Modular Automation System
3) By Application: Hospitals And Private Labs, Biotech And Pharma, Academics And Research Institutes, Other Applications
Subsegments:
1) By Automated Liquid Handlers: Liquid Transfer Systems, Pipetting Robots
2) By Automated Plate Handlers: Plate Stacker Systems, Microplate Transport Systems
3) By Robotic Arms: Single-Axis Robotic Arms, Multi-Axis Robotic Arms
4) By Automated Storage And Retrieval Systems: Sample Storage Systems, Automated Retrieval Systems
5) By Other Types: Nucleic Acid Extraction Systems, Other Custom Automation Solutions
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/lab-automation-in-genomics-global-market-report
Who are the most influential companies in the lab automation in genomics market?
Major companies operating in the lab automation in genomics market report are Pfizer Inc.; Robert Bosch GmbH; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Novartis International AG; GlaxoSmithKline plc; Danaher Corporation; Becton, Dickinson and Company; Agilent Technologies Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Tecan Group Ltd.; Illumina Inc.; Hamilton Company; Promega Corporation; Oxford Nanopore Technologies Ltd.; Fluidigm Corporation; Gilson Incorporated
What are the top industry trends projected to impact the lab automation in genomics market?
Major companies operating in lab automation in the genomics market are focused on developing advanced solutions such as automated whole genome sequencing (WGS), to significantly advance genomics research, clinical diagnostics, and personalized medicine. Automated whole genome sequencing (WGS) is sequencing an individual’s genome using high-throughput, automated sequencing technologies. For instance, in May 2023, Clear Labs, Inc., a US-based genomics testing company, launched Clear Dx. This new solution provides fully automated sample processing, guaranteeing precise and consistent library preparation and management for genomics. Clear Dx automation reduces human variability and promises consistency throughout sequencing, resulting in consistent and reproducible outcomes. It streamlines genome sequencing, cutting hands-on time to just 30 minutes with a single touch point, enabling easy whole genome sequencing even without training.
What are the major regional insights for the lab automation in genomics market, and which region holds the top position?
North America was the largest region in the lab automation in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Lab Automation In Genomics Market Report 2025 Offer?
The lab automation in genomics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Lab automation in genomics refers to the use of advanced technologies and systems to streamline and automate various laboratory processes involved in genomic research and analysis. Lab automation in genomics aims to improve the efficiency, accuracy, and reproducibility of genomic research by reducing manual errors, increasing throughput, and accelerating data analysis.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15206
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
